#ActInTimeDEADLINETime left to limit global warming to 1.5°C 4YRS112DAYS08:29:58 LIFELINEWorld's energy from renewables14.784076279%Ambitious climate action could boost global 2040 GDP by 0.2% | Tanzania’s marine reserves offer long-term benefits to communities | Paris residents vote in favor of making 500 more streets pedestrian | Use of pesticides on UK farms to be cut by 10% by 2030 to protect bees | New forest to be created in England, with 20m trees planted by 2050 | Affordable e-bikes are transforming delivery work for Latin American migrants | California & Sonora sign agreement to boost clean energy & climate collaboration | UK to invest $260 million on solar panels for schools and hospitals | Green power to give 570 million energy access in Africa | UN hails rare success story as emissions from construction stop rising | Ambitious climate action could boost global 2040 GDP by 0.2% | Tanzania’s marine reserves offer long-term benefits to communities | Paris residents vote in favor of making 500 more streets pedestrian | Use of pesticides on UK farms to be cut by 10% by 2030 to protect bees | New forest to be created in England, with 20m trees planted by 2050 | Affordable e-bikes are transforming delivery work for Latin American migrants | California & Sonora sign agreement to boost clean energy & climate collaboration | UK to invest $260 million on solar panels for schools and hospitals | Green power to give 570 million energy access in Africa | UN hails rare success story as emissions from construction stop rising |

Jul 2, 2021

COVID-19 Update

World
New Cases:   432,028 (⬆︎ .24%)
New Deaths:      8,316 (⬆︎ .21%)

USA
New Cases:   16,949 (⬆︎ .05%)
New Deaths:       315 (⬆︎ .05%)

Yesterday, July 1st, 2021
0 Vaccinated people
and
8,316 Un-Vaccinated people
were killed by COVID-19

181.3 million vaccinated
Including 155.9 million people who have been fully vaccinated in the United States.


In the last week, an average of 1.07 million doses per day were administered, a 45% increase over the week before.





Johnson & Johnson says its coronavirus vaccine is effective against delta variant

The Johnson & Johnson coronavirus vaccine provides effective protection against the delta variant, according to a small study, offering hope to many developing economies facing a summer surge of the highly contagious strand.

Blood samples obtained from eight inoculated people who participated in a laboratory study showed that Johnson & Johnson’s single-dose shot generated a strong immune response against the delta variant, the New Brunswick, N.J.-based company said. (The results have not been peer reviewed.) Earlier clinical trials had shown the vaccine offered 66 percent protection against symptomatic infection.

“We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant,” Paul Stoffels, chief scientific officer at Johnson & Johnson, said in a news release. “This adds to the robust body of clinical data supporting our single-shot vaccine’s ability to protect against multiple variants of concern.”

Why is the Johnson & Johnson vaccine only one shot? Here’s what to know.

The data so far indicates that the three U.S.-approved vaccines offer effective protection against all known variants of the virus. Analysis by British health authorities, drawing on data from a large pool of people, indicates that the Pfizer-BioNTech messenger RNA vaccine provides 96 percent protection against hospitalization from the delta variant, which was first detected in India.

- more -
Labels:

4 comments:

  1. Allan S7/02/2021 2:31 PM

    Happy to report that the Mexican Navy gave me and the wife the first vaccination, and in 90 days we get our second shot. The Mexican government just wants everyone vaccinated. We are happy.

    ReplyDelete
  2. eVille Mike7/03/2021 4:52 AM

    Yay, Allan. And yay Mexico. Feel OK?

    ReplyDelete
  3. Allan S7/05/2021 5:24 PM

    Fluish and achy the second day. Fine now.

    ReplyDelete

Subscribe to: Post Comments (Atom)